Web

  • http://www.drugs.com/mtm/dutasteride.html
  • Dutasteride is used to treat benign prostatic hyperplasia (BPH) in men with an enlarged prostate.
  • http://www.medicines.org.uk/emc/medicine/11618
  • The recommended dose of Avodart is one capsule (0.5 mg) taken orally once a day.
  • http://www.netdoctor.co.uk/medicines/liver-kidney-and-urinary-sys...
  • Avodart is used to relieve moderate to severe symptoms of BPH and to reduce the risk of developing a complete inability to pass urine (acute urinary retention) that may require surgery.
  • http://www.wikidoc.org/index.php/Dutasteride
  • WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling.
  • http://www.nps.org.au/medicines/urinary-system-and-sex-organs/bla...
  • Avodart Capsules is a brand of medicine containing the active ingredient dutasteride.
  • http://www.uwhealth.org/health/topic/multum/avodart/d04788a1.html
  • Dutasteride should never be taken by a woman or a child.
  • http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8b9c7f0b-...
  • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use dutasteride capsules safely and effectively.
  • http://www.hairloss-reversible.com/articles/hn6.htm
  • Dutasteride is the generic name for the new prostate drug that is now being marketed as Avodart.
  • http://www.Hairsite.com/hair-loss-dutasteride.htm
  • But if you just want to read about forum summaries and important issues about Avodart or Dutasteride on an ongoing basis, this page will be very helpful.
  • http://www.drugbank.ca/drugs/DB01126
  • Dutasteride is a synthetic 4-azasteroid compound that is a selective inhibitor of both the type 1 and type 2 isoforms of steroid 5 alpha-reductase (5AR), intracellular enzymes that convert testosterone to 5 alpha-dihydrotestosterone (DHT)....
  • 1 2 3 4 5 6 7 8 9

    Videos

    Dr. McKay Discusses Dutasteride in Prostate Cancer
         
    Rana R. McKay, MD, a clinical oncology fellow at Dana-Farber Cancer Institute, Boston, Massachusetts, explains the mechanism of action of dutasteride and its role in a phase II trial where abiraterone acetate was combined with dutasteride in men with meta...

    Research Summaries ; Cancer.Net
           
    A new study on the drug dutasteride (Avodart) showed that it can slow the growth of early-stage prostate cancer for men whose prostate cancer is being monitored with a method called active surveillance.

    Dr. McKay Discusses Dutasteride in Prostate Cancer
           
    Rana R. McKay, MD, a clinical oncology fellow at Dana-Farber Cancer Institute, Boston, Massachusetts, explains the mechanism of action of dutasteride and its role in a phase II trial where abiraterone acetate was combined with dutasteride in men with meta...

    Drug lowers prostate cancer risk
           
    Lowering prostate cancer risk: A new study finds that dutasteride significantly reduces the chances that men at high risk of prostate cancer will be diagnosed with the kinds of tumors that are most often treated excessively: those that fall in the mid-r...

    Prostate Enlargement Treatment Part 5
           
    http://www.balancedhealthtoday.com http://www.balancedhealthtoday.com/endosterol.html What are the possible prostate enlargement treatments? 1. Drugs Common medications for prostate enlargement treatment are Finasteride and Dutaste

    Avodart Videos
           
    Avodart Videos

    Clint, Epilepsy Patient, and Neurosurgeons - Video Library - Newsroom - Barnes-Jewish Hospital
           
    Dutasteride Reduces Risk of Prostate Cancer

    Prostate cancer study proves drug delays disease progression
           
    (TORONTO, Canada -- Jan. 24, 2012) -- For men diagnosed with low-risk, localized prostate cancer, being treated with the drug dutasteride ("Avodart") delays disease progression and initiating active treatment, and also reduces anxiety, show the result...

    Drug lowers prostate cancer risk
           
    Lowering prostate cancer risk: A new study finds that dutasteride significantly reduces the chances that men at high risk of prostate cancer will be diagnosed with the kinds of tumors that are most often treated excessively: those that fall in the mid-r...

    Images

    220px Avodart
    217px Dutasteride svg
    485px Dutasteride svg
    120px Dutasteride svg
    Dutasteride structural formula
    220px Avodart
    en.wikipedia.org
    217px Dutasteride svg
    en.wikipedia.org
    485px Dutasteride svg
    en.wikipedia.org
    120px Dutasteride svg
    en.wikipedia.org
    Dutasteride structural formula
    drugs.com
    Avodart 0.5 mg
    Avodart
    DUTASTERIDE
    Dutasteride is a white to pale yellow powder with a melting point of 242 to 250C.
    Image of Avodart 0.5 mg
    Avodart 0.5 mg
    drugs.com
    Avodart
    drugs.com
    DUTASTERIDE
    drugs.com
    Dutasteride is a white to pale yellow powder with a melting point of 242
    drugs.com
    Image of Avodart 0.5 mg
    uwhealth.org
    Chemical structure of dutasteride.
    Avodart 0.5 mg GX CE2
    Dutasteride 0.5 mg A 75
    Dutasteride 0.5 mg A 0.5
    Jalyn (dutasteride / tamsulosin) 0.5 mg / 0.4 mg
    Chemical structure of dutasteride.
    drugs.com
    Avodart 0.5 mg GX CE2
    drugs.com
    Dutasteride 0.5 mg A 75
    drugs.com
    Dutasteride 0.5 mg A 0.5
    drugs.com
    Jalyn (dutasteride / tamsulosin) 0.5 mg / 0.4 mg
    drugs.com
    Dutasteride is a white to pale yellow powder with a melting point of 242 to 250C.
    Effect on Acute Urinary Retention or the Need for BPH-Related Surgery: After 4 years of treatment, combination therapy with dutasteride and tamsulosin did not provide benefit over monotherapy with dutasteride in reducing the incidence of AUR or BPH-relate
    Dutasteride structure 01
    Summary of Clinical Trials: Data from 3 large, well-controlled efficacy trials demonstrate that treatment with dutasteride (0.5 mg once daily) reduces the risk of both AUR and BPH-related surgical intervention relative to placebo, improves BPH-related sym
    Dutasteride panel 01.png
    Dutasteride is a white to pale yellow powder with a melting point of 242
    drugs.com
    Effect on Acute Urinary Retention or the Need for BPH-Related Surgery: After 4 years of treatment, combination therapy with dutasteride and tamsulosin did not provide benefit over monotherapy with dutasteride in reducing the incidence of AUR or BPH-relate
    dailymed.nlm.nih.gov
    Dutasteride structure 01
    wikidoc.org
    Summary of Clinical Trials: Data from 3 large, well-controlled efficacy trials demonstrate that treatment with dutasteride (0.5 mg once daily) reduces the risk of both AUR and BPH-related surgical intervention relative to placebo, improves BPH-related sym
    dailymed.nlm.nih.gov
    Dutasteride panel 01.png
    wikidoc.org
    Dutasteride structural formula
    Dutasteride label 01.png
    Dutasteride is a white to pale yellow powder with a melting point of 242 to 250C.
    Dutasteride clilnical studies 07
    DUTASTERIDE 0.5mg 90 ct label
    Dutasteride structural formula
    dailymed.nlm.nih.gov
    Dutasteride label 01.png
    wikidoc.org
    Dutasteride is a white to pale yellow powder with a melting point of 242
    dailymed.nlm.nih.gov
    Dutasteride clilnical studies 07
    wikidoc.org
    DUTASTERIDE 0.5mg 90 ct label
    dailymed.nlm.nih.gov
    Dutasteride clilnical studies 05
    Avodart 0.5mg 30 ct label
    Dutasteride clilnical studies 04
    Dutasteride clilnical studies 03
    Effect on Acute Urinary Retention or the Need for BPH-Related Surgery: After 4 years of treatment, combination therapy with dutasteride capsules and tamsulosin did not provide benefit over monotherapy with dutasteride capsules in reducing the incidence of
    Dutasteride clilnical studies 05
    wikidoc.org
    Avodart 0.5mg 30 ct label
    dailymed.nlm.nih.gov
    Dutasteride clilnical studies 04
    wikidoc.org
    Dutasteride clilnical studies 03
    wikidoc.org
    Effect on Acute Urinary Retention or the Need for BPH-Related Surgery: After 4 years of treatment, combination therapy with dutasteride capsules and tamsulosin did not provide benefit over monotherapy with dutasteride capsules in reducing the incidence of
    dailymed.nlm.nih.gov
    Dutasteride clilnical studies 02
    Summary of Clinical Trials: Data from 3 large, well-controlled efficacy trials demonstrate that treatment with dutasteride capsules (0.5 mg once daily) reduces the risk of both AUR and BPH-related surgical intervention relative to placebo, improves BPH-re
    Dutasteride clilnical studies 01
    Dutasteride adverse 02
    Dutasteride adverse 01
    Dutasteride clilnical studies 02
    wikidoc.org
    Summary of Clinical Trials: Data from 3 large, well-controlled efficacy trials demonstrate that treatment with dutasteride capsules (0.5 mg once daily) reduces the risk of both AUR and BPH-related surgical intervention relative to placebo, improves BPH-re
    dailymed.nlm.nih.gov
    Dutasteride clilnical studies 01
    wikidoc.org
    Dutasteride adverse 02
    wikidoc.org
    Dutasteride adverse 01
    wikidoc.org
    Summary of Clinical Studies: Data from 3 large, well-controlled efficacy studies demonstrate that treatment with dutasteride (0.5 mg once daily) reduces the risk of both AUR and BPH-related surgical intervention relative to placebo, improves BPH-related s
    Dutasteride 0.5 mg NDC 0173-0712.jpg
    Effect on Acute Urinary Retention or the Need for BPH-Related Surgery: After 4 years of treatment, combination therapy with dutasteride and tamsulosin did not provide benefit over monotherapy with dutasteride in reducing the incidence of AUR or BPH-relate
    avodart 8
    avodart 7
    Summary of Clinical Studies: Data from 3 large, well-controlled efficacy studies demonstrate that treatment with dutasteride (0.5 mg once daily) reduces the risk of both AUR and BPH-related surgical intervention relative to placebo, improves BPH-related s
    dailymed.nlm.nih.gov
    Dutasteride 0.5 mg NDC 0173-0712.jpg
    wikidoc.org
    Effect on Acute Urinary Retention or the Need for BPH-Related Surgery: After 4 years of treatment, combination therapy with dutasteride and tamsulosin did not provide benefit over monotherapy with dutasteride in reducing the incidence of AUR or BPH-relate
    dailymed.nlm.nih.gov
    avodart 8
    rxlist.com
    avodart 7
    rxlist.com

    MORE IMAGES